Advertisement

Topics

Latest "Longas Technologies Pty Ltd" News Stories

21:56 EDT 24th June 2019 | BioPortfolio

Here are the most relevant search results for "Longas Technologies Pty Ltd" found in our extensive news archives from over 250 global news sources.

More Information about Longas Technologies Pty Ltd on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Longas Technologies Pty Ltd for you to read. Along with our medical data and news we also list Longas Technologies Pty Ltd Clinical Trials, which are updated daily. BioPortfolio also has a large database of Longas Technologies Pty Ltd Companies for you to search.

Showing "Longas Technologies" News Articles 1–25 of 4,000+

Monday 24th June 2019

Amring Pharmaceuticals Announces the Launch of Two Valued Pharmaceutical Generics

Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical and ophthalmic medical device company, announced today that it has launched two valued drugs into its generic portfolio and to the U.S. Market: Succinylcholine Chloride Injection, a generic of Quelicin®, launched in April 2019, is used as an adjunct to general anesthesia to facilitate tracheal intubation, and it also provides skel...


Prospective RCT Highlights Technical Success and Performance of Cook Medical’s 20 Gauge ProCore FNB Needle

A newly published prospective, randomised controlled trial concluded that 20 gauge fine needle biopsy (FNB) needles consistently outperformed 25 gauge fine needle aspiration (FNA) needles in terms of histological yield and diagnostic accuracy in pancreatic and non-pancreatic gastrointestinal lesions. The data reported a 99% technical success rate for 20 gauge FNB needles (success was defined as t...

Fujifilm unveils echocardiography technology at ASE 2019

The conference takes place June 21-25, 2019 at the Oregon Convention Center in Portland, OR. “At Fujifilm, our goal is to offer cardiologists and other clinicians best-in-breed technologies The post Fujifilm unveils echocardiography technology at ASE 2019 appeared first on NS Medical Devices.


Prospective RCT Highlights Technical Success and Performance of Cook Medical’s 20 gage ProCore FNB Needle

A newly published prospective, randomized controlled trial concluded that 20 gage fine needle biopsy (FNB) needles consistently outperformed 25 gage fine needle aspiration (FNA) needles in terms of histological yield and diagnostic accuracy, in pancreatic and non-pancreatic gastrointestinal lesions. The data reported a 99% technical success rate for 20 gage FNB needles (success was defined as the...

Bioasis Announces Allowances of Patent Applications in the U.S. and Europe Relating to xB3 Platform Technology and Key Therapeutic Indications

U.S. Patent Office and European Patent Office issue allowances of patent applications relating to iduronate-2-sulfatase (“IDS”) polypeptide/xB3 conjugates European Patent Office issues allowance of patent application relating to trastuzumab/xB3 conjugates including xB3-001, Bioasis’ lead product in development for the treatment of HER2+ breast cancer brain metastases Bioasis Technologi...

Thailand presents the Benefits of Cold Pressed Virgin Rice Bran Oil

BANGKOK, June 24, 2019 /PRNewswire/ -- The Department of Foreign Trade, Ministry of Commerce, Thailand, has introduced a project called "Think RICE, Think THAILAND" to encourage international community to pay attention to consumer health and to raise awareness on the national crop by providing a wider range of knowledge about Thai rice. Today, by using modern technologies and cutting-edg...

Catalent Announces Pricing of Private Offering of Senior Unsecured Notes Due 2027

Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. (the “Operating Subsidiary”), priced a private offering (the “Private Offering”) of $500.0 million in aggregate ...

ASRC Federal Subsidiary Selected to Continue Support of the Defense Medical Information Exchange (DMIX) Program

The Data Network Technologies team will provide systems integration and sustainment for the DMIX products, including operations and sustainment for DMIX development, test, and production environments and clinical terminology mapping services. BELTSVILLE, Md. (PRWEB) June 24, 2019 ASRC Federal Data Network Technologies has been awarded the Defense Medical Information Exchange (DMIX) Sustainment &a...

Germinated Brown Rice Baby Food, A Delicious Rice for Child's Development

BANGKOK, June 24, 2019 /PRNewswire/ -- The Department of Foreign Trade, Ministry of Commerce, Thailand, has introduced a project called "Think RICE, Think THAILAND" to encourage international community to pay attention to consumer health and to raise awareness on the national crop by providing a wider range of knowledge about Thai rice. Today, by using modern technologies and cutting-edg...

Cannabis stock news: Namaste Technologies (TSXV: N) (OTCMKTS: NXTTF) Continues Push Towards Becoming World's Leading Cannabis Marketplace Through Agreement With True Leaf (OTCQX: TRLFF) (CSE: MJ)

TORONTO - June 24, 2019 (Newsfile Corp.) (Investorideas.com Newswire) Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced that it has signed a supply and purchase agreement with True Leaf Brands Inc. (OTCQX: TRLFF) (CSE: MJ) (DEUTSCHE BORSE: TLA) to market and distribute a line of hemp-based supplements for pets through its online mar...

Early Studies Show EBTATE is Well Tolerated and Effective in Treating Neuroendocrine Tumors

Molecular Targeting Technologies, Inc. (MTTI) announced today that Professor Zhaohui Zhu et. al. of the Department of Nuclear Medicine, Peking Union Medical College Hospital (PUMC), Beijing, China will present a talk entitled “Safety and Response of an Evans Blue-modified 177Lu-labeled Octreotate (EBTATE) in Treatment of Metastatic Neuroendocrine Tumors:...

Expedeon AG introduces Lightning-Link Metal Labeling Kits to support single cell analysis. Novel antibody labeling immunoassay technology for multiplex immune profiling addresses one of the fastest growing, billion-dollar life science market sectors

Heidelberg, Germany and Cambridge, UK, 24 June 2019: Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) announced today it has introduced Lightning-Link® Metal Labeling Kits for use in multiple immunoassay-based applications to support single cell analysis. The new kits will enable users to dramatically enhance the phenotypic analysis of heterogeneous cell populations, provi...

Atomwise and Enamine to Advance Pediatric Oncology With the World’s First and Largest Ten Billion Compound Virtual Screen

Atomwise, Enamine, and top university researchers collaborate to discover novel small molecules for the treatment of pediatric cancers using the power of AI and novel chemistry. Atomwise, Inc. today announced the launch of a 10 billion compound AI-powered virtual drug screening initiative, the 10-to-the-10 program, in collaboration with Enamine Ltd., the world’s largest chemical supplier. The ...

Avellino Labs Founder Gene Lee Receives 2019 Ellis Island Medal of Honor, Named to World Economic Forum’s Precision Medicine Council

Company’s Visionary Leader Recognized for His Pioneering Work in Genetic Diagnostic and Therapeutic Technologies Avellino Labs, a global biotechnology and genetic science innovator, announced today the company’s founder, chairman and president, Gene Lee, is a recipient of a 2019 Ellis Island Medal of Honor. In addition, Lee has been appointed to the World Economic Forum’s Precision Medicin...

TheraCann Adds Blockchain Functionality to ETCH biotrace Platform Powered by Applied DNA 

ETCH biotrace to Combine Applied DNA’s DNA tag-based Forensic Traceability and Authenticity with TruTrace's Industry Blockchain Hub to Deliver Unparalleled Tag-Test-Track Capabilities to Global Cannabis and Hemp Industry Applied DNA Sciences, Inc. (“Applied DNA”, NASDAQ: APDN), announced today that its cannabis and hemp industry partner, TheraCann

Agilent Introduces Breakthrough Flow Cytometer

Agilent Technologies Inc. (NYSE: A) today introduced its first new product from recently acquired ACEA Biosciences, at the 34th Congress of the International Society for Advancement of Cytometry, CYTO 2019 Congress, being held June 22–26, 2019 in Vancouver, Can

Ocutrx's augmented reality headset shows promise in AMD correction

A pre-pilot trial of Ocutrx Vision Technologies' Oculenz AR glasses has been successfully completed, demonstrating up to 5 li -More- 

Catalent Announces Launch of Private Offering of $500 Million of Senior Unsecured Notes Due 2027

Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. (the “Operating Subsidiary”), intends to offer, subject to market and other conditions, $500 million in aggregate pr...

STAT Plus: The FDA erred in approving new women’s libido drug; don’t reward Palatin Technologies

Opinion: Women struggling with sexual dysfunction, like men struggling with sexual dysfunction, deserve safe, efficacious treatments. But Vyleesi is not the answer.

The FDA erred in approving new women’s libido drug; don’t reward Palatin Technologies

Opinion: Women struggling with sexual dysfunction, like men struggling with sexual dysfunction, deserve safe, efficacious treatments. But Vyleesi is not the answer.

Novanta Signs Agreement to Acquire ARGES

Combined capabilities will provide intelligent subsystems for demanding laser-based applications Laser World of Photonics – Novanta, a trusted technology partner to medical and advanced industrial equipment manufacturers, announced today that it has signed an agreement to acquire ARGES GmbH, based in Wackersdorf, Germany. ARGES develops and manufactures intelligent subsystems for positioning...

International Vet Health Businesses Converge in Charlottetown

For the next three days, industry leaders in veterinary health and nutrition will meet in Charlottetown for the seventh biennial VetHealth Global™, North America's foremost business conference for this industry. More than 200 global animal health businesses, executives from new and emerging companies, regulators and investors will meet at the PEI Convention Centre in the Delta Prince Edward H...

Expedeon AG: Expedeon AG introduces Lightning-Link(R) Metal Labelling Kits to support single cell analysis (news with additional features)

DGAP-News: Expedeon AG / Key word(s): Product Launch 24.06.2019 / 08:30 The issuer is solely responsible for the content of this announcement. PRESS RELEASE 24 June 2019   Expedeon AG introduces Lightning-Link(R) Metal Labelling Kits to support single cell analysis Novel antibody labelling immunoassay technology for multiplex immune profiling addresses one of the fastest growing...

EVOTEC, SENSYNE HEALTH, THE UNIVERSITY OF OXFORD, OSI, AND OUI CREATE NEW BRIDGE PARTNERSHIP 'LAB10X' IN DIGITAL HEALTH

DGAP-News: Evotec SE / Key word(s): Contract 24.06.2019 / 07:54 The issuer is solely responsible for the content of this announcement. - LAB10X FOCUSES ON ACCELERATING DATA-DRIVEN HEALTHCARE SOLUTIONS POWERED BY ARTIFICIAL INTELLIGENCE ("AI") - GOAL IS TO ACCELERATE PROOF-OF-CONCEPT IN DIGITAL HEALTH Hamburg, Germany, and Oxford, UK, 24 June 2019: Evotec SE (Frankfurt Stock Exchange: ...

EMMAC Life Sciences Ltd To Partner with Hyris Ltd to develop Unique Real-Time Phyto-Cannabinoid Rich technology for the specific identification of proprietary cultivars of Cannabis subsp.

EMMAC, the European independent medical cannabis company, is pleased to announce an exclusive collaboration with Hyris Ltd, a UK-based biotechnology company, to develop a comprehensive library of genetic profiles of existing cannabis varieties, and to industrialise DNA-based methods for the identification of its unique branded cultivars. The Hyris platform will enable EMMAC to gain an exact ove...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks